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FUNDING OPPORTUNITIES 
 
2018 Pilot Grant Program for 
CDKL5 Deficiency Disorder 
The Orphan Disease Center (ODC) at the 
University of Pennsylvania and the Loulou 
Foundation are pleased to announce the 2018 Pilot 
Grant Program for CDKL5 Deficiency Disorder 
(CDD). CDD is a monogenic, orphan condition 
characterized by treatment-resistant epilepsy and 
severe cognitive and motor disability. The Loulou 
Foundation and the ODC will provide a one-year 
grant for $150,000.00 (total cost) to support 
research related to CDD – number of awards may 
vary.   
 
Eligibility: 
 
All individuals holding a faculty‐level appointment at 
an academic institution or a senior scientific 
position at a non-profit institution or foundation are 
eligible to respond to this RFA. All applicants must 
first submit a letter of Interest (LOI) to be reviewed 
for consideration of a full application 
submission. LOIs can be uploaded via this form, 
also found at :  
 
http://orphandiseasecenter.med.upenn.edu/grant-
opportunities/cdkl5-program-of-excellence  
 
LOIs due by March 8, 2018 at 5pm (EST)  
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Damon Runyon-Sohn Cancer 
Fellowship Award 
224K Prizes for Scientists and Clinicians  
The Damon Runyon Cancer Research 
Foundation, the leading charity supporting 
innovative young cancer researchers, and the 
Sohn Conference Foundation, dedicated to 
curing pediatric cancers, partnered to 
establish the Damon Runyon-Sohn Pediatric 
Cancer Fellowship Award. This award 
provides funding to basic scientists and 
clinicians who conduct research with the 
potential to significantly impact the prevention, 
diagnosis or treatment of one or more 
pediatric cancers.  
 
Applicants are not required to be pediatricians 
or members of pediatric departments; 
however, the proposed research must have 
direct relevance to one or more pediatric 
cancers.  
 
The goal of this Fellowship Award is to recruit 
the top young minds to research childhood 
cancers. It leverages the success of the 
internationally-renowned Damon Runyon 
Fellowship Award, which has an unparalleled 
track record for identifying future breakthrough 
scientists. 
  
Deadline: March 15, 2018 
 
 
 
  
 
PhRMA Foundation Fellowship in Regulatory 
Science 
$70K Annual Stipend 
 
Request for Applications 
 
The PhRMA Foundation funds scientists at critical points in their research careers to support and 
reward innovation in disciplines essential to the development of safe and effective medicines 
through our fellowship and grant programs.  
Regulatory Science is the science of developing new tools, standards, and approaches to 
assess the safety, efficacy, quality, and performance of all FDA-regulated products. FDA-
regulated products include medical products (i.e., drugs, devices, biologics), food, and tobacco 
products. This program will support Fellows focusing on medicine and medical products 
exclusively. The Fellowships include a paid annual stipend of $70,000 
 
Deadline for applications: April 1, 2018 
For more information: www.phrmafoundation.org. 
____________________________________________________________________________________ 
UMass Lowell has been awarded the I-Corps site grant. This allows UMass Lowell’s 
New Venture Department to fund research projects across UMass Lowell, UMass 
Boston, UMass Medical School, UMass Dartmouth and Middlesex Community 
College.!!  
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To learn more about the program, please see the I-Corps website following URL and download 
our pdf flyer: 
 
https://www.uml.edu/innovation-Entrepreneurship/New-Venture-Initiative/ICORPS/ 
 
To apply, please fill out the online application form: http://bit.ly/umlcorpsapplication 
___________________________________________________________________________________ 
EVENTS 
 
SAVE-THE-DATE: 
 
7th Annual Community Engangement and Research Symposium 
 
The 7th Annual Community Engagement and Research Symposium is part of the five-campus 
clinical and translational science movement across the University of Massachusetts. It is 
sponsored by the UMass Center for Clinical and Translational Science Community Engagement 
and Research component. 
 
March 9, 2018 
8:00am - 3:00pm 
Albert Sherman Center 
University of Massachusetts Medical School, Worcester  
 
The goal of the symposium is to build our shared capacity to address health issues in 
communities throughout Massachusetts by creating opportunities for people to meet each other, 
learn more about each other's work and interests, and make connections and plan for future 
collaborative work. 
Audience: Community leaders, faculty and staff from all 5 UMass campuses and other 
organizations and institutions interested in partnered research. 
 
Registration Deadline is February 16, 2018. 
 
____________________________________________________________________________________ 
Boston University  
Interdisciplinary 
Biomedical Research Office 
(IBRO) 
- 
Creating  & Connecting  
Research 
 
Presents 
BU Technology Wonders: Potential Biomedical Applications 
 
Date: March 28th, 2018  
Time: 2:00 pm to 5:00 pm 
Location:  Room x714, Evans Biomedical Research Center, 650 Albany Street 
 
Addess inquiries to Dr. Katya Ravid via Robin MacDonald at: remac@bu.edu 
 
___________________________________________________________________________________ 
 
Cancer Biology Program Research Retreat 
to be held at the  
Hogan Campus Center at the College of the Holy Cross 
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 Monday, April 2, 2018 
 
Keynote Speaker 
William Sellers, M.D.  
Broad Institute, Dana-Farber Cancer Institute 
 
* Please Register at https://www.eventbrite.com/e/umms-cancer-biology-
program-research-retreat-tickets-42440453539  
 
____________________________________________________________________________________ 
SAVE-THE-DATE: 
 
Tuesday, May 1, 2018, 1:30 pm Faculty Conference Room 
 
An afternoon to celebrate The Diabetes Center Excellence and its people. UMass has for 
years been and remains a leading institution for diabetes research and care. Clearly, the 
force driving that excellence is its people.  
 
Keynote Speaker: Jeffrey Friedman, M.D., Ph.D., Professor, Rockefeller University, 
Investigator, Howard Hughes Medical Institute. 
The event will also include a poster session, prizes and research/care awards. 
More information to follow shortly. 
 
________________________________________________________________________ 
FOR YOUR INFORMATION: 
 
For your reference and information, PDFs of the five Skills Series workshop presentations in 
Scholarly Publishing and Communication offered throughout this past fall are now available 
online at: https://libraryguides.umassmed.edu/research/scholcomm_skills_series. 
  
They cover: 
  
·        Finding and Evaluating Journals 
·        Working with NCBI 
·        Sharing Your Research 
·        Identity Management with ORCID and Other Tools 
·        Keeping Track of Your Impact 
____________________________________________________________________________________ 
NIH CLINICAL AND TRANSLATIONAL RESEARCH COURSE FOR PhD 
STUDENTS: 
 
The NIH is hosting a free Clinical and Translational Research Course for PhD Students July 9-
20, 2018, at the NIH main campus in Bethesda, MD. Students will learn the process of clinical 
and translational research from concept to implementation. The application deadline is Friday, 
March 30, 2018, 5:00 PM EDT. 
For more information, please email phdcourse@cc.nih.gov. 
 
_____________________________________________________________________________ 
FDA Voice Blog: 
 
Bringing Early Feasibility Studies for Medical Devices Back to the United States 
 
Ten years ago, when medical device manufacturers wanted to gain early clinical experience with their new 
devices they often went overseas to conduct first-in-human or small clinical studies. Moving a device from 
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bench to bedside for use in patients is a critical step along the development path. However, going overseas 
delayed access to potentially beneficial devices for American physicians and patients.  
 
Today, FDA’s Center for Devices and Radiological Health (CDRH) has an Early Feasibility Studies Program 
(EFS) that provides a route for innovators, sponsors, FDA review teams, and clinicians to work together to 
facilitate the early clinical evaluation of medical devices in the United States under the investigational 
device exemption (IDE) regulations.  
 
An EFS is a limited clinical study on a device early in its development, typically before the device design 
has been finalized, for a specific indication. It may be used to evaluate the device design concept with 
respect to initial clinical safety and device functionality. The EFS Program includes enhanced opportunities 
for collaboration, increased regulatory flexibility, and consideration of benefit-risk principles, while 
maintaining appropriate patient protection measures. 
 
..Continue reading 
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